USPTO serial 98601029
DIGITAL COUNTER
Reviewed by CopyMark Law Group
Status 672
- Filing date
- Status date
- Registration date
- —
- Examiner
- SINGH, DEEP K
- Law office
- PETITIONS OFFICE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DIGITAL COUNTER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Austin, TX, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ashley N. Klein
Ashley N. Klein Bradley Arant Boult Cummings LLP1230 Peachtree Street NE, Suite 2100Promenade TowerAtlanta, GA 30309Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Software as a Service (SAAS) services featuring software for use by pharmacies and their patients, namely, business management software; Software as a Service (SAAS) services featuring software for electronic communication between pharmacies and their patients, namely, communications via Short Message Service (SMS), email, voice, and secure in-app web portal messaging; Software as a Service (SAAS) services featuring software for use by pharmacies and their patients, namely, non-downloadable software for managing pharmacy-patient relationships, namely, managing prescriptions and prescription refill orders, managing and scheduling appointments and providing appointment reminders, collecting and storing insurance information, and processing payment transactions; Software as a Service (SAAS) services featuring software for use by pharmacies, namely, non-downloadable software for patient education, including providing digital health education; Software as a Service (SAAS) services featuring software for use by pharmacies, namely, non-downloadable software for providing secondary insurance to patients; Software as a Service (SAAS) services featuring software for use by pharmacies, namely, non-downloadable software for providing discounts and coupons to patients; Software as a Service (SAAS) services featuring software for use by pharmacies, namely, non-downloadable software for providing payment processing for both e-commerce and in-store purchasers; Software as a Service (SAAS) services featuring software for use by pharmacies, namely, non-downloadable software for digital marketing, including text message campaigns, website banners, promotional cards, newsletters, and social media content and managing customer loyalty programs; Software as a Service (SAAS) services featuring software for use by pharmacies, namely, non-downloadable software for patient management, including creating, distributing, and managing patient forms and surveys and generating reports and benchmarking; Software as a Service (SAAS) services featuring software for use by pharmacies and their patients, namely, non-downloadable software for enabling personalized guidance and recommendations for patients; Software as a Service (SAAS) services featuring software for use by pharmacies for enabling digital patient interactions, namely, secure communications, appointment scheduling, and medication management; Software as a Service (SAAS) services featuring software for website and mobile application development; Software as a Service (SAAS) services featuring software for website and mobile application development, namely, non-downloadable software for use by pharmacies and their patients to create, maintain, and manage websites and mobile software applications that provide health and medication information, discounts and coupons, prescription refill ordering, waitlist registrations, health news resources, the ability to sign up for clinical trials, send messages, manage digital marketing campaigns, and view metrics and reports; Software as a Service (SAAS) services featuring software for patient engagement, namely, non-downloadable software for facilitating real-time conversations between patients and pharmacists, task management, and clinical opportunity management, namely, identifying, tracking, and optimizing clinical opportunities within healthcare settings to improve patient outcomes, operational efficiency, and financial performance; Software as a Service (SAAS) services featuring software for digital marketing, namely, creating targeted advertising, social media content, and branded graphics and videos; Software as a Service (SAAS) services featuring software for use by pharmacies, namely, non-downloadable software for providing digital wellness resources, namely, medication videos, downloadable medication guides, patient education sheets, and vaccination information sheets; Software as a Service (SAAS) services featuring software for Customer Relationship Management (CRM), namely, non-downloadable software for managing interactions between pharmacies and patients; Software as a Service (SAAS) services featuring software for use in providing call center communications, operations, and management; Software as a Service (SAAS) services featuring software for use in providing call center and telecommunications functionality, namely, predictive dialing, call recording, call reporting, voicemail archiving, voice recognition, interactive voice response systems, and interactive transaction processing systems; Software as a Service (SAAS) services featuring software for payment processing; Software as a Service (SAAS) services featuring business management software for use in the e-commerce industry; Software as a Service (SAAS) services featuring software for use by pharmacies to create, maintain, and manage websites and mobile software applications that provide health and medication information, discounts and coupons, prescription refill ordering, and the ability to sign-up for clinical trials; Software as a service (SAAS) services featuring software for use by pharmacies, namely software enabling pharmacies to create and deliver electronic newsletters and social media content to patients. | ACTIVE | Jun 3, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 14, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 5, 2026 | RGRR | REINSTATEMENT GRANTED - RESPONSE RECEIVED | — |
| Feb 4, 2026 | APET | ASSIGNED TO PETITION STAFF | — |
| Dec 10, 2025 | ERRS | TEAS REQUEST FOR REINSTATEMENT | — |
| Nov 29, 2025 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 29, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 10, 2025 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Nov 10, 2025 | IUAF | USE AMENDMENT FILED | — |
| Nov 10, 2025 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| Nov 10, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 7, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Aug 7, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| May 8, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 8, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 8, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 13, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 13, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 13, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 19, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 19, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 19, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 14, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 14, 2024 | NWAP | NEW APPLICATION ENTERED | — |